Table 2.
Liposome type/formulation/test method | Target against | Reference | |
---|---|---|---|
For vaccine developments | Lipopeptide vaccine | Group A Streptococcus | Ghaffar et al., 2016 |
Mannosylated ionic liposome vaccine | HIV DNA vaccine | ||
PEB modified liposome with CRX-601 | Influenza vaccine | Oberoi et al., 2016 | |
Peptide-based liposome | Antitumor vaccine | Kakhi et al., 2015 | |
Liposome constituting microneedles | Oral mucosal vaccination | Zhen et al., 2015 | |
Liposome containing E-protein vaccine | Tembusu virus vaccine in duck | Ma et al., 2016 | |
Ophiopogon polysaccharide liposome | Parvovirus vaccine | Fan et al., 2016 | |
For detection strategies | Liposome-encapsulated spin-trap (LEST) | Nitric oxide | Hirsh et al., 2016 |
Liposome-based microcapillary immunosensor | E. coli | Ho et al., 2004 | |
GM incorporated liposome piezoelectric agglutination | Cholera toxin | Yu et al., 2011 | |
Secretory proteins encapsulated liposome-based detection | Mycobacterium tuberculosis | Tiwari et al., 2015 | |
Immunoliposomes-based assays | Salmonella, Cronobacter | Shukla et al., 2012, 2016c | |